Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma

BACKGROUND: The clinicopathologic characteristics of tumors expressing programmed death (PD-1) ligands (PD-Ls) PD-L1 or PD-L2 and their associations with common driver mutations in lung adenocarcinoma are not clearly defined, despite the progression of anti-PD-1/PD-L1 immunotherapy. METHODS: PD-L1 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Wang, Lei, Li, Yuan, Pan, Yunjian, Wang, Rui, Hu, Haichuan, Li, Hang, Luo, Xiaoyang, Ye, Ting, Sun, Yihua, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990506/
https://www.ncbi.nlm.nih.gov/pubmed/24748806
http://dx.doi.org/10.2147/OTT.S59959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990506/
https://www.ncbi.nlm.nih.gov/pubmed/24748806
http://dx.doi.org/10.2147/OTT.S59959

Ejemplares similares